Eisai
Chip Zug currently serves as the Global Analytics & Insights Lead for the Global Alzheimer's Disease Office at Eisai US, where responsibilities include leading a team focused on forecasting and analytics to support a significant Alzheimer's treatment strategy. Prior experience includes a role as Global Insights & Analytics Leader at ViiV Healthcare, managing a diverse team to optimize business strategies, and holding leadership positions such as New Products Leader and Market & Portfolio Strategy Leader at GlaxoSmithKline, directing impactful market analysis in the field of infectious diseases. Early career roles include financial analysis at JP Morgan and Hambrecht & Quist, where management of substantial client portfolios was a key responsibility. Educational credentials include an MBA from the University of Virginia Darden School of Business and a BA in History & PreMed from the University of Virginia.
This person is not in any teams
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.